Mediators of inflammation at the maternal-fetal interface are altered by SARS-CoV-2 infection and pandemic stress
- PMID: 36680541
- DOI: 10.1111/aji.13679
Mediators of inflammation at the maternal-fetal interface are altered by SARS-CoV-2 infection and pandemic stress
Abstract
Problem: It is now recognized that SARS-CoV-2 infection and pandemic-related stress impacts maternal health. However, their effects at the maternal-fetal interface are still debated.
Method of study: We recruited 199 women between March 2020 and July 2021, 79 SARS-CoV-2+ and 120 negative (the latter exposed to pandemic stress only). We also included 40 historic controls (i.e. pre-pandemic uncomplicated pregnancies recruited before March 2020). Placental samples were collected for protein and histological analysis.
Results: The majority of SARS-CoV-2+ women were multiethnic, had higher pre-pregnancy BMI and elevated preterm birth rate (17%) vs SARS-CoV-2- or historic control. Placental inflammatory profile revealed increased IL-1Ra and CRP, independently of SARS-CoV-2 status, whilst MCP-1, IL-6 and IFNγ were elevated in the negative, but pandemic stress-exposed, group. These changes were predominant in placentas with inflammatory lesions on histopathological analysis. Furthermore, we observed elevated immune cells (CD45+) in placentas from SARS-CoV-2+ and negative pregnancies vs historic controls, even when individuals with pregnancy complications were excluded.
Conclusions: Placental inflammatory profiles differed between SARS-CoV-2 statuses, namely exposed to pandemic stress +/- SARS-CoV-2 infection. This highlights the need to understand the differences between the effects of pandemic-related stress and the added burden of SARS-CoV-2 infection on placental health.
Keywords: SARS-CoV-2; immunology; inflammation; pandemic; placenta; stress.
© 2023 The Authors. American Journal of Reproductive Immunology published by John Wiley & Sons Ltd.
References
REFERENCES
- 
    - Mirbeyk M, Saghazadeh A, Rezaei N. A systematic review of pregnant women with COVID-19 and their neonates. Arch Gynecol Obstet. 2021;304(1):5-38. doi:10.1007/s00404-021-06049-z
 
- 
    - Regan AK, Arah OA, Fell DB, Sullivan SG. SARS-CoV-2 infection during pregnancy and associated perinatal health outcomes: a National US Cohort Study. J Infect Dis. 2022;225(5):759-767. doi:10.1093/infdis/jiab626
 
- 
    - Shuffrey LC, Firestein MR, Kyle MH, et al. Association of birth during the COVID-19 pandemic with neurodevelopmental status at 6 months in infants with and without in utero exposure to maternal SARS-CoV-2 infection. JAMA Pediatr. 2022:e215563. doi:10.1001/jamapediatrics.2021.5563
 
- 
    - Schoenmakers S, Verweij EJJ, Beijers R, et al. The impact of maternal prenatal stress related to the COVID-19 Pandemic during the first 1000 days: a historical perspective. Int J Environ Res Public Health. 2022;19(8):4710. doi:10.3390/ijerph19084710
 
- 
    - Jash S, Sharma S. Pathogenic infections during pregnancy and the consequences for fetal brain development. Pathogens. 2022;11(2):193. doi:10.3390/pathogens11020193
 
MeSH terms
LinkOut - more resources
- Full Text Sources
- Medical
- Research Materials
- Miscellaneous
 
        